Abstract
<p>ABSTRACT<br />Objective: The antihypertensive drugs (beta-blockers - carvedilol, calcium channel blocker - amlodipine, and angiotensin-converting enzyme<br />inhibitor - enalapril) were investigated for its hepatoprotective effect by antioxidant property against carbon tetrachloride (CCl<br />)-induced acute liver<br />damage on albino rats. <br />Methods: In this study the liver was damaged by giving Carbon tetra chloride (CCl<br />4<br />)-1 ml/kg-p.o. After giving CCl<br /> (1 ml/kg), it significantly elevated<br />the serum levels of biochemical markers such as serum glutamate-pyruvate transaminase, serum glutamic oxaloacetic transaminase, alkaline<br />phosphatase, total bilirubin, protein, and depleted antioxidant enzymes glutathione. After treatment with carvedilol (10 mg/kg), enalapril (0.5 mg/kg),<br />and amlodipine (10 mg/kg) for 2 weeks, these drugs were significantly reduces the elevated levels of biochemical markers mentioned above.<br />Conclusion: These results suggest that these antihypertensive drugs may have the potential therapeutic value in the treatment of CCl<br />4<br />-induced<br />hepatic damage and some liver diseases. Hepatoprotective activity of these drugs may be attributed to the antioxidant principles in it.<br />Keywords: Antioxidant, Carvedilol, Enalapril, Amlodipine, Carbon tetrachloride, Hepatoprotective.<br />4</p><p>4</p>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.